These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat. Harony-Nicolas H, Kay M, du Hoffmann J, Klein ME, Bozdagi-Gunal O, Riad M, Daskalakis NP, Sonar S, Castillo PE, Hof PR, Shapiro ML, Baxter MG, Wagner S, Buxbaum JD. Elife; 2017 Jan 31; 6():. PubMed ID: 28139198 [Abstract] [Full Text] [Related]
5. A proof-of-concept study of growth hormone in children with Phelan-McDermid syndrome. Sethuram S, Levy T, Foss-Feig J, Halpern D, Sandin S, Siper PM, Walker H, Buxbaum JD, Rapaport R, Kolevzon A. Mol Autism; 2022 Jan 29; 13(1):6. PubMed ID: 35093163 [Abstract] [Full Text] [Related]
6. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, Pessoa ALS, Perez ABA, Lourenço N, Vibranovski M, Krepischi A, Rosenberg C, Passos-Bueno MR. J Neurodev Disord; 2019 Jul 18; 11(1):13. PubMed ID: 31319798 [Abstract] [Full Text] [Related]
11. Gait Abnormalities in Children with Phelan-McDermid Syndrome. Frank Y, Levy T, Lozano R, Friedman K, Underwood S, Kostic A, Walker H, Kolevzon A. J Child Neurol; 2023 Dec 04; 38(13-14):665-671. PubMed ID: 37849292 [Abstract] [Full Text] [Related]
12. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder. Richards C, Powis L, Moss J, Stinton C, Nelson L, Oliver C. J Neurodev Disord; 2017 Nov 10; 9(1):37. PubMed ID: 29126394 [Abstract] [Full Text] [Related]
13. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment. Costales JL, Kolevzon A. Neurotherapeutics; 2015 Jul 10; 12(3):620-30. PubMed ID: 25894671 [Abstract] [Full Text] [Related]
15. Brief Report: Sensory Reactivity in Children with Phelan-McDermid Syndrome. Mieses AM, Tavassoli T, Li E, Soorya L, Lurie S, Wang AT, Siper PM, Kolevzon A. J Autism Dev Disord; 2016 Jul 10; 46(7):2508-13. PubMed ID: 26914612 [Abstract] [Full Text] [Related]
16. Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome. Gergoudis K, Weinberg A, Templin J, Farmer C, Durkin A, Weissman J, Siper P, Foss-Feig J, Del Pilar Trelles M, Bernstein JA, Buxbaum JD, Berry-Kravis E, Powell CM, Sahin M, Soorya L, Thurm A, Kolevzon A, Developmental Synaptopathies ConsortiumDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.. Autism Res; 2020 Aug 10; 13(8):1383-1396. PubMed ID: 32406614 [Abstract] [Full Text] [Related]
17. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial. Daniels N, Moerkerke M, Steyaert J, Bamps A, Debbaut E, Prinsen J, Tang T, Van der Donck S, Boets B, Alaerts K. Mol Autism; 2023 Apr 20; 14(1):16. PubMed ID: 37081454 [Abstract] [Full Text] [Related]
18. Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome. Asta L, Ricciardello A, Cucinotta F, Turriziani L, Boncoddo M, Bellomo F, Angelini J, Gnazzo M, Scandolo G, Pisanò G, Pelagatti F, Chehbani F, Camia M, Persico AM. J Neurodev Disord; 2024 Oct 03; 16(1):57. PubMed ID: 39363263 [Abstract] [Full Text] [Related]